News Column


July 8, 2014

BALFOUR BEATTY Berenberg has kept its "buy" rating, while cutting the target price to 280p from 290p. The broker believes that there is a good chance the company is nearing the end of its problems in the UK, with a cheap valuation compared to peers, and the potential to grow revenues significantly.

EXPERIAN UBS has maintained its "buy" rating on the data group, but cut the target price to 1,200p from 1,250p. The broker thinks that there may be a tough quarter ahead, particularly in North America, with a more conservative view of growth improvement through the year.

CLINIGEN Investec has increased its rating to "buy" from "hold", reducing the target price to 497p from 560p. The broker thinks the shares are too cheap to ignore, with a new estimate removing much of the risk associated with the CTS division, with meaningful growth likely to be delivered ahead.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: City A.M. (UK)

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters